What Is Sleep Apnea? Causes, Signs, and Symptoms Explained

The word "apnea" is derived from the Greek for "without breath." Sleep apnea is defined clinically as recurrent episodes of partial or complete cessation of breathing during sleep, each lasting at least 10 seconds, occurring at a frequency that disrupts sleep architecture and reduces blood oxygen levels. That clinical definition, while precise, doesn't fully convey what the condition is like to live with — or why it goes unrecognized for so long in so many people. According to estimates from the American Academy of Sleep Medicine, approximately 30 million Americans have sleep apnea, and roughly 80 percent of them have never been diagnosed.

What Happens During an Apnea Event

To understand sleep apnea, it helps to understand what occurs physiologically during a single apnea event — and why it goes unnoticed by the person experiencing it. As a person with obstructive sleep apnea drifts into deeper sleep, the muscles of the upper airway relax. In individuals with a structurally compromised airway — whether from anatomy, obesity, or positioning — this relaxation allows the airway to narrow or collapse. Airflow stops. Oxygen saturation begins to fall. Carbon dioxide accumulates in the bloodstream. The brain detects the chemical imbalance and triggers a brief arousal — just enough to restore airway muscle tone and restart breathing, typically with a gasp, snort, or choking sound. Then the patient falls back asleep. The entire sequence takes seconds to a minute, and the arousal is almost never sufficient to reach conscious wakefulness. The person has no memory of it.

In moderate-to-severe sleep apnea, this cycle repeats fifteen to sixty or more times per hour — every hour, across the entire night. A patient sleeping eight hours with an AHI of 30 experiences roughly 240 of these events before waking. Each one fragments sleep architecture, briefly spikes blood pressure and heart rate, and contributes to the cumulative oxygen debt that produces the condition's daytime and systemic effects. "Patients are often skeptical when I explain what's happening overnight," says Dr. Rachel Simone, a sleep researcher at the Stanford Center for Sleep Sciences and Medicine. "They say they sleep fine. But sleeping and sleeping well are not the same thing."

Causes and Anatomical Factors

The causes of obstructive sleep apnea — the most common type — are rooted in upper airway anatomy and physiology. Several structural features increase OSA susceptibility by narrowing the effective diameter of the pharyngeal airway:

• Large tonsils or adenoids: Particularly significant in children, where adenotonsillar hypertrophy is the leading cause of pediatric OSA
• Retrognathia: A recessed or small jaw places the tongue in a position that encroaches on the posterior airway space
• Enlarged soft palate or uvula: Excess tissue in the oropharynx reduces the clearance between the palate and the posterior pharyngeal wall
• Macroglossia: An enlarged tongue relative to jaw size reduces airway patency, particularly in the supine position
• High, arched palate: Associated with a narrower palatal vault and reduced nasal cross-sectional area

These anatomical factors operate in combination with physiological factors — particularly obesity, which deposits fat in the parapharyngeal spaces and around the upper airway, mechanically reducing its caliber. Reduced neuromuscular tone during sleep (influenced by alcohol, sedatives, and stage of sleep) is the dynamic factor that determines whether a vulnerable airway actually collapses. Central sleep apnea, by contrast, does not involve anatomical obstruction — it occurs when the brain's respiratory control centers fail to send an adequate signal to the breathing muscles. For a detailed comparison of all three sleep apnea types, see our guide to sleep apnea types and symptoms.

Risk Factors

Several demographic and clinical characteristics significantly elevate OSA risk:

Sex

Men are diagnosed with OSA at roughly two to three times the rate of premenopausal women. The difference is attributed to sex differences in fat distribution (men accumulate more parapharyngeal fat), upper airway anatomy, and respiratory control. After menopause, women's risk increases substantially and approaches that of age-matched men — a pattern that implicates estrogen and progesterone as protective factors in premenopausal women.

Age

OSA prevalence increases with age through midlife, driven by progressive loss of upper airway muscle tone, redistribution of body fat, and reduced arousal thresholds. Prevalence estimates in adults over 65 range from 30 to 60 percent, though severe OSA is somewhat less common in the very elderly.

Obesity

Obesity is the strongest modifiable risk factor for OSA. A 10 percent increase in body weight is associated with a six-fold increase in OSA odds. Neck circumference — a proxy for upper airway fat deposition — is independently associated with OSA risk; thresholds of greater than 17 inches in men and greater than 16 inches in women are commonly used in clinical screening tools.

Nasal congestion

Chronic nasal obstruction — whether from rhinitis, polyps, or structural deviation — increases the negative pressure required to inhale, promoting airway collapse in susceptible individuals. Effective treatment of nasal obstruction can meaningfully reduce OSA severity in some patients.

Signs vs. Symptoms: The Clinical Distinction

"Signs" and "symptoms" are distinct clinical concepts. Signs are observations made by an outside observer — a clinician, partner, or family member. Symptoms are reported by the patient. This distinction matters in sleep apnea because the most clinically telling signs often require a witness to observe.

The primary signs of OSA — those observable by a bed partner — are loud, habitual snoring; witnessed apneas (pauses in breathing followed by resumption); and gasping or choking sounds. "A bed partner who reports witnessed apneas is one of the most diagnostically useful pieces of information in my history," says Dr. James Whitfield, a pulmonologist and sleep medicine specialist at Cleveland Clinic. "It substantially increases the probability of OSA beyond what symptoms alone convey."

The symptoms patients themselves report are more varied and often less specific: persistent fatigue despite adequate time in bed; cognitive fog and difficulty concentrating; irritability or low mood; morning headaches; dry mouth; and nocturia (waking to urinate one or more times per night). These symptoms are individually non-specific — each can result from many causes — but in combination, particularly alongside risk factors and observed signs, they build a compelling clinical picture. When symptoms are prominent but a bed partner is unavailable, an at-home sleep test can efficiently confirm or exclude OSA without requiring an in-lab overnight study. See our related coverage on how untreated sleep apnea affects health for the downstream consequences of leaving these symptoms unaddressed.

When to Get Evaluated

Clinical guidelines recommend evaluation for OSA in any adult with habitual snoring plus daytime symptoms, witnessed apneas, or relevant comorbidities (hypertension, type 2 diabetes, atrial fibrillation, obesity). Evaluation is also appropriate for any patient with unexplained excessive daytime sleepiness, regardless of snoring history. The threshold for evaluation should be low: diagnosis is now accessible through at-home testing, treatment is effective, and the consequences of prolonged undiagnosed sleep apnea — cardiovascular, metabolic, and cognitive — accumulate over years. The 80 percent who remain undiagnosed are not an abstract statistic; they are individuals accruing biological harm from a treatable condition while attributing their fatigue to aging, stress, or a sedentary lifestyle.

Frequently Asked Questions

What exactly is sleep apnea?

Sleep apnea is a sleep disorder characterized by recurrent episodes of partial or complete cessation of breathing during sleep, each lasting at least 10 seconds. The most common form, obstructive sleep apnea, occurs when the upper airway muscles relax to a degree that causes the airway to collapse and obstruct airflow. The brain triggers a brief arousal to restore breathing, fragmenting sleep. Most patients are unaware these events are occurring.

How many people have sleep apnea?

An estimated 30 million Americans have sleep apnea, according to the American Academy of Sleep Medicine. Approximately 80 percent of those with clinically significant sleep apnea remain undiagnosed. Global prevalence is estimated at over 900 million people with at least mild OSA. Rates have risen in parallel with increasing obesity prevalence and improved diagnostic awareness over the past two decades.

What are the main causes of sleep apnea?

Obstructive sleep apnea is caused by physical collapse of the upper airway during sleep, driven by a combination of anatomical factors (large tonsils, recessed jaw, excess soft tissue) and physiological factors (obesity, reduced muscle tone, sleep stage). Central sleep apnea is caused by failure of the brain's respiratory drive — common in heart failure, with opioid use, or at high altitude. Risk factors for OSA include male sex, obesity, age, large neck circumference, and nasal congestion.

Can you have sleep apnea without snoring?

Yes. While loud habitual snoring is the most commonly reported sign of OSA, not everyone with sleep apnea snores, and not everyone who snores has sleep apnea. Central sleep apnea, in particular, often occurs without significant snoring. Women with OSA are less likely than men to present with the classic loud-snoring pattern. Symptoms like persistent fatigue, morning headaches, dry mouth, and cognitive fog warrant evaluation for sleep apnea even without snoring.

How is sleep apnea diagnosed?

Diagnosis requires sleep testing. The two main options are an in-lab polysomnography (PSG), which monitors brain waves, eye movements, airflow, respiratory effort, oxygen saturation, and cardiac rhythm over a full night, and an at-home sleep test (HST), which measures a more limited parameter set — adequate for uncomplicated OSA. The apnea-hypopnea index (AHI), reported after testing, classifies severity: under 5 is normal, 5–14 is mild, 15–29 is moderate, and 30 or above is severe.